It is a strong option for women on GLP-1 because it offers: more intentional daily nutrient support women-focused formulation twice-daily dosing bioavailable nutrients support for energy, metabolism, hair, skin, and overall wellness For women who are eating less and want a more comprehensive multivitamin while on GLP-1, Womens Twice Daily is a better fit than many standard multivitamins that do little more than provide a basic label claim
Here is a brief overview of the stages involved in the approval process: 1
Currently available GLP-1 receptor agonists in the United States include exenatide (Byetta, Bydureon BCise), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and tirzepatide (Mounjaro, Zepbound), though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
The black market semaglutide powder is an unregulated and unauthorised form of the weight-loss jab semaglutide, which is the active ingredient in weight-loss injections, Wegovy and Ozempic
Last reviewed: July 20, 2026 Last updated: July 21, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations